Related Experiment Videos
A monoclonal antibody recognizing the p150/95 leucocyte differentiation antigen
Immunology
|November 1, 1986
Summary
A new monoclonal antibody, KB90, targets a specific leukocyte differentiation antigen. This antibody binds to the 140 kd subunit of the p150/95 molecule, distinct from LFA-1 and Mac-1, and stains various immune cells.
Area of Science:
- Immunology
- Cell Biology
- Biochemistry
Background:
- Leukocyte differentiation antigens play crucial roles in immune cell function and identification.
- The p150/95 molecule is part of a family of adhesion molecules involved in immune responses.
- Understanding the specific epitopes recognized by antibodies is vital for precise cell characterization.
Purpose of the Study:
- To describe a novel monoclonal antibody, KB90, and its target molecule.
- To characterize the binding epitope of KB90 on the target molecule.
- To determine the immunocytochemical reactivity profile of KB90 on various immune cells and compare it to related molecules.
Main Methods:
- Biochemical dissociation of the target molecule under high pH conditions.
- Epitope mapping using the monoclonal antibody KB90.
- Immunocytochemical analysis of KB90 reactivity on human leukocytes and tissue macrophages.
Main Results:
- Monoclonal antibody KB90 recognizes a molecule composed of 140 kd and 98 kd polypeptide subunits.
- KB90 binds to an epitope on the 140 kd subunit after dissociation.
- The recognized molecule is identified as p150/95, a member of the leukocyte differentiation antigen family.
- Immunocytochemical staining revealed KB90 reactivity on monocytes, macrophages, granulocytes, and a subset of lymphocytes.
- KB90 reactivity patterns are distinct from those observed for LFA-1 and Mac-1 molecules.
Conclusions:
- Monoclonal antibody KB90 is a valuable tool for identifying and characterizing the p150/95 leukocyte differentiation antigen.
- KB90 recognizes a specific epitope on the 140 kd subunit, differentiating it from LFA-1 and Mac-1.
- The distinct reactivity profile of KB90 provides new insights into the heterogeneity of immune cell populations.